Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06034457 · ClinicalTrials.gov registry record
Testing the Effectiveness of WW Clinic GLP1
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 180
- Enrollment target
NCT06034457: Completed study, sponsored by The Cleveland Clinic.
NCT06034457 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06034457 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.
Primary Outcome
Effect of WW GLP1 behavioral program + WW Clinic (formerly known as Sequence) on absolute change of weight loss at 24 weeks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2024-10-17 |
What the finished NCT06034457 record still lists
NCT06034457 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06034457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06034457 about?
NCT06034457 is a clinical study titled "Testing the Effectiveness of WW Clinic GLP1". The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.
What is the current status of trial NCT06034457?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2024-01-18. Estimated completion is 2024-10-17.
Who is sponsoring clinical trial NCT06034457?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI